School of Medicine
Showing 21-30 of 47 Results
-
Y. Katherine Bianco
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioI am Latinx Maternal-Fetal Medicine specialist and Medical Geneticist and a Professor of Obstetrics and Gynecology at Stanford University. I direct the Maternal Heart Program at Stanford Children’s Hospital and Clinics, leading a multidisciplinary team caring for complex cardiac conditions in pregnancy. I am dedicated educator and mentor, that have trained more than 50 trainees spanning from high school students to junior faculty. I serve in the Dean’s Office for Faculty Professional Development and Engagement and oversees the OBGYN Advance and Promotions, where i support advances programs to support faculty growth, mentorship, and academic success. My work integrates genetics, cardiology, and maternal health to improve outcomes for women and families. My clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.
As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor.
With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival.
. My career has been defined by a commitment to addressing the most pressing drivers of maternal morbidity and mortality, particularly cardiovascular disease in pregnancy. I have led multidisciplinary maternal cardiac programs at UCSF and Stanford, impacting over 600 high-risk pregnancies and demonstrating how team-based care transforms outcomes.
Beyond clinical innovation, my work spans translational science and global health. I have contributed to advancing prenatal diagnostics—validating tools for non-invasive prenatal testing, improving detection of conditions like Down syndrome. Globally, I’ve led training initiatives in countries with high maternal mortality, such as India, Guatemala, El Salvador, and Costa Rica, building capacity through education and simulation.
Equally central is mentorship. I have mentored over 50 trainees across all levels, fostering diversity and advancing women in medicine. My work goes beyond language access to cultural humility, improving care for diverse populations.
As a physician who bridges worlds—from my modest beginnings in a lower-middle-income country, through medical training in the U.S., to leading at Stanford—I know that diverse paths shape stronger futures. I believe that every mother’s life saved is a generation empowered—and through science, mentorship, and equity, -
Richard Bland
Professor (Research) of Pediatrics (Neonatology), Emeritus
Current Research and Scholarly InterestsOur research focuses on the pathogenesis and treatment of acute and chronic neonatal lung injury and the mechanisms that regulate lung fluid balance and alveolar & pulmonary vascular development after premature birth.
-
Francis Blankenberg
Associate Professor of Radiology (Pediatric Radiology) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsStudies on apoptotic cell death in vivo using the H MRS phenomenon.
-
Terrence Blaschke
Professor of Medicine and of Molecular Pharmacology, Emeritus
Current Research and Scholarly InterestsClinical pharmacology of antiretroviral drugs
Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.
Drug development -
Helen M. Blau
Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsProf. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.
-
Barbara Block
Charles and Elizabeth Prothro Professor of Marine Sciences, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsThermal physiology, open ocean predators, ecological physiology and tuna biology
-
Paul Bollyky
Stanford Medicine Professor of Infectious Disease and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsBacteriophages, viruses that infect bacteria, are abundant in the human body. However, their contributions to human health and disease are largely unknown. The Bollyky Lab
studies interactions between phages and both their human and bacterial hosts with the goal of developing innovative strategies to improve human health.
